Sanofi, 10% Owner at REGENERON PHARMACEUTICALS, INC. (REGN), sold 240,468 shares at $597.48 ($143.7M) on 2020-06-09, disclosed to the SEC on 2020-06-11.
Seasonal sale ($143.7M) by 10% Owner — this insider has traded REGN in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $597.48 | 120,234 | $71.8M | 50.0% |
| 2 | $597.48 | 120,234 | $71.8M | 50.0% |
| Total | $597.48 avg | 240,468 | $143.7M | 100% |
| Filing → |
| ICVX | BUY | 2021-08-02 | $1.0M | — | Filing → |
| INZY | BUY | 2020-07-29 | $1.3M | — | Filing → |
| REGN | SELL | 2020-05-29 | $2.4B | — | Filing → |